1,441 to 1,450 of 1,452 Results
Jan 2, 2023 -
C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways
JPEG Image - 1007.0 KB -
MD5: 09d779f58bb300917e8f61d7dab2e6f5
Figure 6. Effects of C5aR antagonists on NF-κB signaling pathway activation and TLR4 expression in LPS-stimulated HGFs.(A) Effects of C5aR antagonists on mRNA levels of p65, p-p65, IκBα, p-IκBα and TLR4 in LPS-stimulated HGFs.(B) Effects of C5aR antagonists on protein levels of p... |
Jan 2, 2023 -
C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways
JPEG Image - 4.5 MB -
MD5: 419a93b3d9988aea661ba0fb63c17492
Figure 7. The effects of C5aR antagonists on p-p65 translocation into the nucleus were used to detect by immunoflfluorescence staining.(A-C) LPS+C5aR antagonists group.(D-F) The control group.(G-I) LPS group. The Blue staining represented the nucleus; The green staining was p-p65... |
Jan 2, 2023 -
C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways
JPEG Image - 975.9 KB -
MD5: e31d40908889cc5a560522952d4d06e4
Figure 8. Effects of C5aR antagonists on MAPK signal pathway activation in LPS-stimulated HGFs.(A) Effects of C5aR antagonists on mRNA levels of JNK, p-JNK, c-JUN and p-c-JUN in LPS-stimulated HGFs. (B) Effects of C5aR antagonists on protein levels of JNK, p-JNK, c-JUN, and p-c-J... |
Jan 2, 2023 -
C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways
JPEG Image - 1.3 MB -
MD5: cac855a33823ba41a8249455503be1e1
Figure S1. Effects of LPS and C5aRA on the activity of HGFs using the CCK8 assay. (A) HGFs were treated with LPS at concentrations of 0.1, 1, and 5 μg/mL for 24, 48, and 72 h, respectively. (B) HGFs were treated with C5aRA at concentrations of 0.1, 1, and 5 μg/mL for 24, 48, and... |
Jan 2, 2023 -
C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways
JPEG Image - 3.0 MB -
MD5: 3d3960b130038f3421d122e3949ed393
Figure S2. Effects of different concentrations of LPS on the expression of C5aR, IL-1β, IL-6, and TNF-α mRNA, determined using RT-PCR analysis. (A) C5aR; (B) IL-6; (C) IL-1β; and (D) TNF-α mRNA expression. Data represent the mean ± SEM of three independent experiments. * P < 0.05... |
Jan 2, 2023 -
C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways
JPEG Image - 3.4 MB -
MD5: 2663c792229305b8584174eccbf93ebe
Figure S3. Effects of different concentrations of C5aRA on the expression of C5aR, IL-1β, IL-6, and TNF-α mRNA, determined using RT-PCR analysis. (A) C5aR; (B) IL-6; (C) IL-1β; and (D) TNF-α mRNA expression. Data represent the mean ± SEM of three independent experiments. * P < 0.... |
Jan 2, 2023 -
C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways
JPEG Image - 1.2 MB -
MD5: 7c6fd5205e5631af918798512bb58073
Schematic diagram of mechanism for anti-inflammatory action of C5aR antagonists (W54011). Complement and Toll-like receptors 4 (TLR4) are co-activated in response to lipopolysaccharide (LPS). During the activation of the complement cascade, C5 may be cleaved into its active produ... |
Jan 2, 2023 -
C5aR antagonist inhibits LPS-induced inflammation in human gingival fibroblasts via NF-κB and MAPK signaling pathways
Plain Text - 3.8 KB -
MD5: 24501ebd59c9ae1e9855c1c58c36b01c
|
Jan 2, 2023 - Ciência & Saúde Coletiva
Batista, Joanna d'Arc Lyra; Alves, Rafael José Vargas; Cardoso, Taís Belladona; Moreno, Marcelo; Tiscoski, Katsuki Arima; Polanczyk, Carisi Anne, 2023, "Replication Data for: Efetividade do Trastuzumabe adjuvante em mulheres com câncer de mama HER-2+ no SUS", https://doi.org/10.48331/scielodata.KG1BRG, SciELO Data, V1, UNF:6:twusn2GcEJRPJRyvuyA/9g== [fileUNF]
Banco de dados do artigo. |
Jan 2, 2023 -
Replication Data for: Efetividade do Trastuzumabe adjuvante em mulheres com câncer de mama HER-2+ no SUS
Tabular Data - 12.8 KB - 24 Variables, 90 Observations - UNF:6:twusn2GcEJRPJRyvuyA/9g==
|